| abstract |
Embodiments of the invention provide a method and / or system that may include administering to a patient having one or more disorders associated with TMA and / or TMAO and / or derivatives thereof a therapeutically effective method of a compound for altering or inhibiting one or more CutC enzymes and / or CntA enzymes associated with microorganisms derived from at least one taxon from a set of microorganism taxa. |